SCHEMBL8204077

SCHEMBL8204077

COc1ccc2c(c1)C(N1CCN(Cc3ccc4c(c3)OCO4)CC1)=Nc1ccccc1N2

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 6/20 0.64
DRD2 P14416 6/20 0.61
DRD1 P21728 3/20 0.61
POLB P06746 2/20 0.50
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 3/20 0.49
HTT P42858 3/20 0.49
MAPT P10636 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
HPGD P15428 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C19 P33261 2/20 0.49
LMNA P02545 1/20 0.49
STAT6 P42226 1/20 0.49
HIF1A Q16665 1/20 0.49
S1PR2 O95136 1/20 0.49
THRB P10828 1/20 0.49
CYP2C9 P11712 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8203911 0.89 DRD2 (0.75) DRD2DRD1POLBALDH1A1KDM4E
SCHEMBL8204496 0.86 DRD2 (0.77) CHRM1DRD2DRD1POLBALDH1A1
SCHEMBL8202579 0.84 DRD2 (0.61) CHRM1DRD2DRD1POLBALDH1A1
SCHEMBL8203868 0.82 DRD2 (0.76) CHRM1DRD2DRD1POLBALDH1A1
SCHEMBL29623704 0.81 DRD2 (0.90) CHRM1DRD2DRD1POLBALDH1A1
SCHEMBL8204038 0.81 DRD2 (0.69) CHRM1DRD2DRD1POLBALDH1A1
SCHEMBL9050759 0.80 DRD2 (0.62) DRD2DRD1POLBALDH1A1KDM4E
SCHEMBL8202569 0.80 DRD1 (0.64) DRD2DRD1POLBALDH1A1KDM4E
SCHEMBL8203933 0.79 DRD2 (0.74) CHRM1DRD2DRD1POLBALDH1A1
SCHEMBL5918366 0.79 CHRM1 (1.00) CHRM1DRD2DRD1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6103715-A COMPOUNDS THAT BIND TO THE DOPAMINE D4 RECEPTOR AND THEIR USE AS ANXIOLYTIC AGENTS, TREATMENT FOR SCHIZOPHRENIA, AND DRUG SCREENING; SIDE EFFECT REDUCTIOON ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-08-15 US disclosed
EP-0736024-A1 N-HETEROBICYCLYL-PIPERAZINYL OR-PIPERADINYL TRICYCLIC DERIVATIVES USEFUL AS DOPAMINE RECEPTOR LIGANDS Allelix Biopharmaceuticals Inc. (CA) 1996-10-09 EP disclosed
US-5538965-A TREATMENT OF PSYCHOLOGICAL DISORDERS SUCH AS SCHIZOPHRENIA AND ANXIETY ALLELIX BIOPHARMACEUTICALS INC. (CA) 1996-07-23 US disclosed
WO-1995017400-A1 N-HETEROBICYCLYL-PIPERAZINYL OR-PIPERADINYL TRICYCLIC DERIVATIVES USEFUL AS DOPAMINE RECEPTOR LIGANDS ALLELIX BIOPHARMACEUTICALS INC. (CA) 1995-06-29 WO disclosed